Neck Carcinoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer (NCT05472506) | Ikena Oncology | 2023-03-01 |
Track Neck Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.